(S) Support, (M) Monitoring (A) And (R) Reminder (T) Technology (4) for (M) Mild (D) Dementia
ABOUT SMART4MD PROJECT
SMART4MD project is an EU-scale research project focusing on experimental treatment of mild dementia. There are 11 international partners of this project including Alzheimer Europe.
This project builds on an innovative patient support tool to develop a mHealth application that is specifically targeted to patients with mild dementia. The content and layout of mHealth SMART4MD application, which will be accessible via tablets given to patients during the experimental pilot treatment, will be based on findings from the first stage of the project focused on user-centric design (focus groups, interviews, tests), but generally will be based on simplicity, memory helpers, reminders, photos, information sharing with carers and doctors and easiness of use for the patients.
The SMART4MD tool will help patients to adhere to their treatment, reduce the progression of their illness and share data with their carers and doctors. This will slow the patients’ cognitive and functional decline, avoid carers getting exhausted and reduce costs of emergency care.
Objective 1: Design a new version of the Pow Health platform (called SMART4MD platform) that can be comfortably and reliably used by patients with MD, validated by at least 80% approval rate in focus groups and small scale patient trials.
Objective 2: Show the medical benefits of using the new SMART4MD platform:
- Increase treatment compliance by MD patients from 50% to 60%.
- Reduce functional decline of patients during the first 24 months from diagnosis by 10%.
- Monitor and improve the quality of life for MD patients
- Monitor the mental well-being of carers
Objective 3: Show the economic and financial benefits of using the SMART4MD platform:
- Reduce costs wasted on unused medicine by 50%.
- Reduce costs associated with patients failing to attend appointments by 75%.
- Reduce costs associated with readmission of patients to hospital (for resurgent conditions due to lack of treatment adherence) by 30%.
- Provide overall efficiency savings to the healthcare system of 10% of dementia budget.
Objective 4: Develop sustainable business models for large-scale commercial roll-out of the SMART4MD platform in different scenarios and regions. Include financial models for investment, based on risk-sharing between relevant stakeholders and provide projections for each stakholder’s return on investment to complete the economic argument.